Biotricity, Inc.
BTCY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7 | $13 | $24 | $103 |
| - Cash | $0 | $1 | $1 | $12 |
| + Debt | $26 | $24 | $20 | $15 |
| Enterprise Value | $33 | $36 | $43 | $106 |
| Revenue | $14 | $12 | $10 | $8 |
| % Growth | 14.3% | 25.2% | 26% | – |
| Gross Profit | $11 | $8 | $5 | $5 |
| % Margin | 76.6% | 69.3% | 56.5% | 59.7% |
| EBITDA | -$3 | -$9 | -$16 | -$19 |
| % Margin | -23.3% | -73.7% | -166.7% | -242.6% |
| Net Income | -$8 | -$14 | -$19 | -$29 |
| % Margin | -61.1% | -116.8% | -193.6% | -380.8% |
| EPS Diluted | -0.55 | -1.66 | -2.26 | -3.99 |
| % Growth | 66.9% | 26.5% | 43.4% | – |
| Operating Cash Flow | -$2 | -$7 | -$14 | -$15 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$7 | -$14 | -$15 |